20. November 2009 00:04
Researchers have shown how an experimental drug might restore the function of nerves damaged in spinal cord injuries by preventing short circuits caused when tiny "potassium channels" in the fibers are exposed.
[More]
18. November 2009 08:24
CNSBio Inc. will present recent Phase IIa proof-of-concept clinical trial data for CNSB015, an orally administered potassium channel modulator used in combination with opioids for the treatment of neuropathic pain, at the 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain on November 20-21, 2009 in San Francisco, CA.
[More]
17. November 2009 04:13
Research and Markets (http://www.researchandmarkets.com/research/63cb3f/dealmaking_and_ind) has announced the addition of Decision Resources, Inc.'s new report "Dealmaking and Industry Outlook: Neurological Disease" to their offering.
[More]
3cce24a5-df8d-4ff4-91db-360afa454a74|0|.0
Posted in: Medical Condition News
Tags: Alzheimer's Disease, Autophagy, Calcium, Cell, Epilepsy, Fibroblast, Gene Therapy, Huntington's Disease, Immunotherapy, Insomnia, Macrophage, Migraine, Multiple Sclerosis, Myelin, Neurological Disease, Neurology, Parkinson's Disease, Pfizer, Potassium, Potassium Channel, Restless Legs Syndrome, Stem Cell, Stroke
27. October 2009 06:47
Reportlinker Adds Ion Channel Modulator Pipelines: Targets and Agents in Development
[More]
b93d183d-3e54-472a-b77b-d8bfbf242761|0|.0
Posted in: Pharmaceutical News
Tags: Alzheimer's Disease, Anxiety, Biotechnology, Calcium, Cardiovascular Disease, Cystic Fibrosis, Depression, Dronedarone, Epilepsy, Fibrosis, Glaucoma, Oncology, Parkinson's Disease, Potassium, Potassium Channel, Schizophrenia, Tinnitus
21. September 2009 02:15
Genes previously known to be essential to the coordinated, rhythmic electrical activity of cardiac muscle -- a healthy heartbeat -- have now also been found to play a key role in thyroid hormone (TH) biosynthesis, according to Weill Cornell Medical College researchers.
[More]
125df9a7-a355-4e9b-b393-aec88ac1a385|0|.0
Posted in: Medical Science News
Tags: Alopecia, Arrhythmia, Atrial Fibrillation, Baldness, Biopsy, Bone, Bone Marrow, Brain, Cancer, Cervical Cancer, Deep Brain Stimulation, Dwarfism, Education, Gene Therapy, Genetics, Hospital, Hypothyroidism, Neuroscience, Obesity, Parkinson's Disease, Penicillin, Pharmacology, Potassium, Potassium Channel, Pregnancy, Psychiatry
11. September 2009 00:25
NeuroMetrix, Inc., today announced that it has completed its private placement of common stock and warrants. Gross proceeds from the offering were approximately $18.7 million.
[More]
9. September 2009 02:46
NeuroMetrix, Inc., a healthcare company transforming patient care through neurotechnology, today announced that it has obtained commitments from institutional investors to purchase approximately $18.68 million of its common stock in a private placement.
[More]
24. August 2009 12:07
Valeant Pharmaceuticals International today announced preliminary results from its Phase IIa proof-of-concept clinical trial of retigabine for the treatment of pain associated with postherpetic neuralgia (PHN), a painful and common complication of shingles.
[More]
8a34b78d-9cdc-47a1-be46-493d53d719d1|0|.0
Posted in: Drug Trial News
Tags: Amnesia, Dermatology, Diarrhea, Epilepsy, Headache, Herpes, Herpes Zoster, Nausea, Neuralgia, Neurology, New Drug Application, Potassium, Potassium Channel, Shingles, Speech, Virus
24. August 2009 01:49
Cholesterol can affect the flow of the electrical currents that generate the heart beat, according to a study from two UBC cardiovascular researchers funded by the Heart and Stroke Foundation of BC & Yukon. The research team has just published the important discovery about the causes of cardiac arrhythmias (abnormal heartbeats) in one of the world's leading scientific journals.
[More]
12. May 2009 06:54
Researchers at UMDNJ-Robert Wood Johnson Medical School are one step closer to determining how human cells can be protected against the affects of age-related neurodegeneration including Alzheimer's and Parkinson's disease.
[More]
80432e33-e9c0-454d-829e-87f4ae621883|1|5.0
Posted in: Medical Research News
Tags: Alzheimer's Disease, Cardiovascular Disease, Cell Metabolism, DNA, Metabolism, Nervous System, Neurodegeneration, Neuroscience, Oxidative Stress, Parkinson's Disease, Physiology, Potassium, Potassium Channel, Stress
5. May 2009 19:07
A study on schizophrenia has implicated machinery that maintains the flow of potassium in cells and revealed a potential molecular target for new treatments. Expression of a previously unknown form of a key such potassium channel was found to be 2.5 fold higher than normal in the brain memory hub of people with the chronic mental illness and linked to a hotspot of genetic variation.
[More]
a11293e8-fc98-4fb3-99c9-9b23123af441|0|.0
Posted in: Medical Research News
Tags: Antipsychotic, Arrhythmia, Brain, Cortex, Dopamine, Gene Expression, Genetics, Hippocampus, Magnetic Resonance Imaging (MRI), Mental Health, Neuron, Potassium, Potassium Channel, Psychosis, Schizophrenia
4. May 2009 21:29
Carnegie Mellon University researchers have identified a new anticonvulsant compound that has the potential to stop the development of epilepsy. The findings are published in the March issue of the journal Epilepsia.
[More]
16. March 2009 22:12
Yale researchers investigating the genetic causes of blood pressure variation have identified a previously undescribed syndrome associated with seizures, a lack of coordination, developmental delay and hearing loss.
[More]
2. February 2009 13:13
A century-old drug that failed in its original intent to treat tuberculosis but has worked well as an antileprosy medicine now holds new promise as a potential therapy for multiple sclerosis and other autoimmune diseases.
[More]
29. January 2009 05:18
Results of a pre-clinical study of leconotide, an investigative calcium channel blocker, shows it has the potential to be safe, selective, and efficacious as a new non-opioid treatment for pain relief. It also holds promise in multiple drug delivery options including nasal spray, transdermal patch, and pills. Data were presented today at the American Academy of Pain Medicine's 25th Annual Meeting.
[More] 
Subscribe